5 results
Keyword Wilate Remove keyword
-
List item
National expert: Ana Boban, European Medicines Agency (updated)
- Declaration of interests - 43.58 KB | PDF
- Curriculum Vitae - 25.89 KB | PDF
inhibitors Past 01-08- 2020 01-08- 2021 Octapharma Wilate von Willebrand disease Current 01-12- 2021 NovoNordisk … -
List item
Human medicine European public assessment report (EPAR): Roctavian
valoctocogene roxaparvovec,
Date of authorisation: 24/08/2022,
, 
, 
, Revision: 3, Authorised, Last updated: 12/09/2023
-
List item
Human medicine European public assessment report (EPAR): Voncento
Human coagulation factor VIII, human von willebrand factor, Hemophilia A; von Willebrand Diseases
Date of authorisation: 12/08/2013, Revision: 15, Authorised, Last updated: 13/05/2022 -
List item
Referral: Factor VIII
associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017 -
List item
Public data from Article 57 database
Last updated: 09/10/2023